PT90210A - Processo esteroespecifico para a preparacao de enantiomeros de furo{3,4-c}piridina - Google Patents

Processo esteroespecifico para a preparacao de enantiomeros de furo{3,4-c}piridina

Info

Publication number
PT90210A
PT90210A PT90210A PT9021089A PT90210A PT 90210 A PT90210 A PT 90210A PT 90210 A PT90210 A PT 90210A PT 9021089 A PT9021089 A PT 9021089A PT 90210 A PT90210 A PT 90210A
Authority
PT
Portugal
Prior art keywords
steroespecific
pyridine
fan
preparation
steroespecific process
Prior art date
Application number
PT90210A
Other languages
English (en)
Other versions
PT90210B (pt
Inventor
Charles Eck
Marc Bonato
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of PT90210A publication Critical patent/PT90210A/pt
Publication of PT90210B publication Critical patent/PT90210B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
PT90210A 1988-04-06 1989-04-06 Processo esteroespecifico para a preparacao de enantiomeros de furo{3,4-c}piridina PT90210B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888808001A GB8808001D0 (en) 1988-04-06 1988-04-06 Stereospecific preparative process for furol(3,4-c)pyridine derivatives

Publications (2)

Publication Number Publication Date
PT90210A true PT90210A (pt) 1989-11-10
PT90210B PT90210B (pt) 1994-06-30

Family

ID=10634633

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90210A PT90210B (pt) 1988-04-06 1989-04-06 Processo esteroespecifico para a preparacao de enantiomeros de furo{3,4-c}piridina

Country Status (28)

Country Link
US (1) US5026855A (pt)
EP (1) EP0337858B1 (pt)
JP (1) JP2680456B2 (pt)
KR (1) KR970005308B1 (pt)
AT (1) AT397093B (pt)
AU (1) AU616753B2 (pt)
BE (1) BE1003843A4 (pt)
CA (1) CA1338475C (pt)
CH (1) CH680000A5 (pt)
DK (1) DK167020B1 (pt)
DZ (1) DZ1335A1 (pt)
ES (1) ES2057159T3 (pt)
FI (1) FI93116C (pt)
FR (2) FR2629821B1 (pt)
GB (2) GB8808001D0 (pt)
IE (1) IE61915B1 (pt)
IN (1) IN172987B (pt)
MA (1) MA21529A1 (pt)
MY (1) MY104424A (pt)
NL (1) NL8920307A (pt)
NZ (1) NZ228614A (pt)
OA (1) OA09247A (pt)
PT (1) PT90210B (pt)
SE (1) SE509130C2 (pt)
SG (1) SG40492G (pt)
TN (1) TNSN89043A1 (pt)
WO (1) WO1989009772A1 (pt)
ZA (1) ZA892477B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
CA2537180A1 (en) * 2003-08-29 2005-03-10 Cotherix, Inc. Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
US20080312241A1 (en) * 2007-01-03 2008-12-18 Gilead Sciences, Inc. Cicletanine and PKC inhibitors in the treatment of pulmonary and cardiac disorders
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
US8377911B2 (en) 2009-10-09 2013-02-19 Merck Sharp & Dohme Corp. Diuretics
WO2015103445A1 (en) * 2013-12-31 2015-07-09 Rockey Don C Systems, methods, techniques, and compounds in research and treatment of portal hypertension and other conditions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IN156817B (pt) * 1981-02-10 1985-11-09 Scras
IN160104B (pt) * 1983-04-05 1987-06-27 Scras
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
GB2137618B (en) * 1983-04-05 1986-05-08 Scras Furo-(3,4-c)-pyridine derivatives
ZA842029B (en) * 1983-04-05 1984-10-31 Scras Furo-(3,4-c)-pyridine derivatives preparation thereof and therapeutic compositions containing the same
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8422029D0 (en) * 1984-08-31 1984-10-03 Scras 6-substituted-furo-(3 4-c)-pyridine derivatives
GB8422379D0 (en) * 1984-09-05 1984-10-10 Scras Derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
FR2629820A1 (fr) 1989-10-13
DK611689A (da) 1989-12-05
PT90210B (pt) 1994-06-30
MA21529A1 (fr) 1989-12-31
FR2629820B1 (fr) 1993-12-03
SE509130C2 (sv) 1998-12-07
JPH02504394A (ja) 1990-12-13
KR970005308B1 (ko) 1997-04-15
TNSN89043A1 (fr) 1991-02-04
GB8808001D0 (en) 1988-05-05
DK611689D0 (da) 1989-12-05
SE8904104D0 (sv) 1989-12-05
DZ1335A1 (fr) 2004-09-13
FR2629821A1 (fr) 1989-10-13
CA1338475C (en) 1996-07-23
MY104424A (en) 1994-03-31
SG40492G (en) 1992-06-12
AU616753B2 (en) 1991-11-07
NL8920307A (nl) 1990-03-01
EP0337858B1 (fr) 1994-06-08
NZ228614A (en) 1990-11-27
FI93116C (fi) 1995-02-27
IE891076L (en) 1989-10-06
IE61915B1 (en) 1994-11-30
DK167020B1 (da) 1993-08-16
KR900700483A (ko) 1990-08-13
ZA892477B (en) 1989-12-27
SE8904104L (sv) 1989-12-05
GB8927509D0 (en) 1990-06-13
FR2629821B1 (fr) 1993-12-03
US5026855A (en) 1991-06-25
BE1003843A4 (fr) 1992-06-30
GB2235194A (en) 1991-02-27
GB2235194B (en) 1992-01-29
JP2680456B2 (ja) 1997-11-19
IN172987B (pt) 1994-01-15
AU3419089A (en) 1989-11-03
CH680000A5 (pt) 1992-05-29
FI895826A0 (fi) 1989-12-05
AT397093B (de) 1994-01-25
FI93116B (fi) 1994-11-15
WO1989009772A1 (fr) 1989-10-19
EP0337858A1 (fr) 1989-10-18
OA09247A (fr) 1992-06-30
ES2057159T3 (es) 1994-10-16
ATA900589A (de) 1993-06-15

Similar Documents

Publication Publication Date Title
PT84316B (pt) Processo para a preparacao de cicloalcano {1,2 -b} indole-sulfamidas
BR8902297A (pt) Processo para a preparacao de 1,1,1,2-tetrafluoretano
BR8803759A (pt) Processo para a preparacao de 2,2,6,6-tetrametil-4-piperidilaminas
PT89705A (pt) Processo para a preparacao de 2', 3'-didesoxi-2', 2'-difluoronucleosidos
PT94059A (pt) Processo para a preparacao de copolimetros hidrossoluveis, de n-vinilamidas
BR9003345A (pt) Processo para a preparacao de 1,1,1,2-tetrafluoretano
PT91188A (pt) Processo para a preparacao de derivados de furano
PT84561B (pt) Processo aperfeicoado para a preparacao de derivados macrolidos
BR8605269A (pt) Processo para preparacao de(2,2)-paraciclofano
PT90210A (pt) Processo esteroespecifico para a preparacao de enantiomeros de furo{3,4-c}piridina
BR8906327A (pt) Processo para a preparacao de organoclorossilanos
PT92365A (pt) Processo para a preparacao de (s)-alfa-etil-2-oxo-1-pirrolidinoacetamida
PT92539A (pt) Processo para a preparacao de derivados de anfotericina b
PT91027A (pt) Processo para a preparacao de derivados peptidicos
PT89775A (pt) Processo para a preparacao de derivados de isoquinolina
BR8903367A (pt) Processo para a preparacao de organoclorossilanos
PT93736A (pt) Processo para a preparacao de n,n'-ditrimetoxi-benzoil-piperazinas 2- substituidas
PT87946A (pt) Processo para a preparacao de derivados 4-amino susbtituido-1,2-dihidroxinaftaleno
BR8902030A (pt) Processo para a preparacao de n-fosfonometilglicina
BR9003346A (pt) Processo para a preparacao de 1,2-dicloro-1,1,2-trifluoretano
PT92507A (pt) Processo para a preparacao de alfa-ciano-beta-oxopropionamidas
BR8906056A (pt) Processo para a preparacao de alcanosulfonamidas
PT90588A (pt) Processo para a preparacao de dibenzotiofenos substituidos
PT90188A (pt) Processo para a preparacao de aril-dionas ou de heteroaril-dionas
PT83636B (pt) Processo para a preparacao de 5-aril-2,4-dialquil-3h-1,2,4-triazole-3-tionas

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19931206

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040630